Merit Medical Q4 revenue $355M (+9.4%); Non-GAAP EPS $0.93 (+25.8%); FY 2025 guidance issued

MERIT MEDICAL SYSTEMS INC

2024-FY EPS reported $2.03 revenue$1,356,514,000

Q4 2024 revenue $355.2M, up 9.4% YoY; constant currency revenue up 10.1%; organic constant currency up 6.1%.
Non-GAAP EPS $0.93, up 25.8%; GAAP EPS $0.46, down 2.6%. Non-GAAP operating margin improved to 19.6% from 16.6%.
Full year 2024 revenue $1.357B (+7.9%); Non-GAAP EPS $3.46 (+21.3%); free cash flow $185.7M (+67.5%).
Completed acquisition of Cook Medical lead management portfolio; FDA PMA received for Wrapsody dialysis device.
FY 2025 guidance: revenue $1.47-1.49B (8-10% growth); Non-GAAP EPS $3.58-$3.70 (4-7% growth).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.